AzTrials
AzTrials

Depressive DisordersNCT00841737

Evaluation of a Psychoeducation Group Program for Mild/Moderate Depression

A study testing Psychoeducational group in people with Depressive Disorders, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 2 sites in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effectiveness and efficiency of doing a psychoeducational group program and the conventional treatment versus individual conventional care in patients with a mild/moderate depression disorder,in urban primary healthcare centers in Barcelona city. Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Depressive Disorders
What is being tested?
Psychoeducational group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
192 participants
Where
2 sitesSpain
Study dates
Jan 2008to Apr 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Beck Depression Inventory(BDI)>10 and <30.
  • Diagnosis of mild/moderate depressive disorders.
  • Signed the Informed Consent.

Who cannot join

  • Patients diagnosed of severe mental psychiatric disorder,
  • Patients diagnosed of a major depressive disorders,
  • Patients with acute illness or near-terminal medical illness,
  • using secondary mental health services,
  • suicidal ideation or intentions,
  • don't speak and understand spanish or/and catalan language,
Show all 10Show fewer
  • sensory or cognitive disabilities,
  • illiteracy,
  • does not know or not give consent to participate in the study,
  • temporary residents.

Trial locations and contacts

2 sites in 1 country.

Rocio Casañas Sánchez, Psychologist contact

0034. 695560597

rocio.casanas@chmcorts.com; rcasanas@gencat.cat

Spain2 sites, 2 recruiting
  • Primary Health Care . Catalan Health Institute (ICS)

    Barcelona, Barcelona, 08023

    Rocio Casañas, Psychologist, 0034.695.56.05.97, rocio.casanas@chmcorts.com; rcasanas@gencat.cat

    Rocio Casañas

    Recruiting
  • Primary health care. Catalan Health Institute (ICS)

    Barcelona, Barcelona, 08023

    Rocio Casañas, Psychologist, 0034.695.56.05.97, rocio.casanas@chmcorts.com; rcasanas@gencat.cat

    Antonia Raya, Nurse

    Recruiting

Other trials in Spain

About this study

Official title: Evaluation of the Effectiveness and Efficiency of a Psychoeducational Group Sessions Intervention Program in the Depressive Episode Realized by Primary Health Care Center Nurses in Barcelona City.

The purpose of this study is to compare the effectiveness and efficiency of doing a psychoeducational group program and the conventional treatment versus individual conventional care in patients with a mild/moderate depression disorder,in urban primary healthcare centers in Barcelona city.

Read the detailed description

Nowadays, the depression is one of the public health major issues, this is because of its prevalence and its economic and social repercussions. It is fundamental for the Primary Care to assume the management of these health problems.

Design:A randomised controlled trial of two groups (intervention and control), longitudinal and prospective.

Population of study: The subjects of the study are patients of 20 to 65 years old attended in 8 urban primary healthcare centers of Barcelona city, identified by the general practitioners and nurses with diagnosis of mild/moderate depression disorder according to the BDI scale.

The intervention group receive weekly a psychoeducational group program during 12 weeks run by 2 nurses. The program have a structured content where patient is educated about the illness, pharmacological treatment, the adherence to treatment, diet and physical exercise, problem solving, and cognitive-behavioral therapy.

In the control group the depression in treated as usual with the conventional care.

Measure's tool: The evolution of patients will be monitoring up to 1 year after the inclusion by a individual interview (the first visit and 3,6 and 9 months).The Beck Depression inventory (BDI) is a self-administered questionnaire that measure the symptomatology and severity of the depression.

The analysis variables are: patient's quality of life (EuroQoL-5D scale) ,clinical variables of the patient, pharmacological prescription, anxiolytics and antidepressants consumption , sociodemographic, number of visits to primary healthcare center, number of days of labour lost and cost.

Being tested
Psychoeducational group, Control Group
Keywords
Depressive Disorders;, Primary Health Care;, Nurses;, Health education.
Medical subject headings
Depressive Disorder, Health Education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychoeducational groupOther

    Also called Psychoeducational group;, Depression group intervention.

    The intervention group receive weekly a psychoeducational group during 12 weeks run by 2 nurses. The program have a structures contend.

  • Control GroupOther

    Also called conventional treatment group;, usual care group

    In the control group the depression is treated as usual with the conventional treatment.

Study groups in NCT00841737
Study groupRoleWhat they receive
Psychoeducational group interventionExperimentalPsychoeducational group received weekly a psychoeducational intervention during a period of 12 weeks run by a nurses.
Receives: Other: Psychoeducational group
Control groupActive comparatorIndividual conventional care
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To measure the symptomatology of the depression by Beck Depression Inventory (BDI) It's a self-administered questionnaire with 21 items (multiple-choice)to measure the intensity, severity and depth of depression.

    Measured: First visit and 3, 6 and 9 months.

Secondary outcomes (1)
  1. To measure the patient's quality of life by the EuroQoL questionnaire; number of visits to primary health care center( doctor and nurse); number of days of labour lost; pharmacological prescription; antidepressant and anxiolytics consumption.

    Measured: First visit and 3,6 and 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2009 (estimated)
  2. Study startJan 2008
  3. Primary completionJul 2009
  4. Study completionApr 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
192 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00841737
Sponsor's protocol ID
PI07/90712
Status last verified
Aug 2009
First submitted
3 Feb 2009
Last updated
6 Aug 2009
Results posted
No
Data monitoring committee
Yes

Publications

  • Casanas R, Catalan R, del Val JL, Real J, Valero S, Casas M. Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial. BMC Psychiatry. 2012 Dec 18;12:230. doi: 10.1186/1471-244X-12-230.

    PubMed 23249399

Questions about this trial

What is this clinical trial studying?

A study testing Psychoeducational group in people with Depressive Disorders, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 2 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Aug 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Rocio Casañas Sánchez, Psychologist (0034. 695560597, rocio.casanas@chmcorts.com; rcasanas@gencat.cat), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To measure the symptomatology of the depression by Beck Depression Inventory (BDI) It's a self-administered questionnaire with 21 items (multiple-choice)to measure the intensity, severity and depth of depression. (time frame: First visit and 3, 6 and 9 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00841737, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in